Neetour Medical

Company Overview

Snapshot

Founded in September 2010 by Ofer Hornick, MD, Neetour Medical operated with 1–10 employees. The company's technology was selected to be part of the Samsung Mobile SimBand wearable project, a watch-style platform designed for continuous vital diagnostic information.

Business overview

Neetour Medical developed Capno-Pulse, a noninvasive technology designed to monitor carbon dioxide (CO2) levels in the blood. This technology analyzes photoplethysmography (PPG) by sampling blood volume changes through light reflection using infrared and visible light sensors. The company's solutions cater to a wide range of applications in well-being, sports, and healthcare, serving markets that include B2B, B2C, and B2G segments globally within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Neetour Medical's primary technology?

Neetour Medical developed Capno-Pulse, a noninvasive technology that monitors carbon dioxide (CO2) levels in the blood by analyzing photoplethysmography (PPG) through light reflection using infrared and visible light sensors.

When was Neetour Medical founded?

Neetour Medical was founded in September 2010.

Who is the founder of Neetour Medical?

Ofer Hornick, MD, is the founder and CTO of Neetour Medical.

What markets does Neetour Medical serve?

Neetour Medical serves global markets, with business models including B2B, B2C, and B2G, focusing on applications in well-being, sports, and healthcare.

What was a key application of Neetour Medical's technology?

Neetour Medical's technology was integrated into the Samsung Mobile SimBand wearable project, a platform designed for continuous vital diagnostic information for lifestyle, medical, and sports-related uses.